Yang J et al. |
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. |
2012 |
World J. Gastroenterol. |
pmid:22826618
|
Chen ZS et al. |
Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. |
2007 |
World J. Gastroenterol. |
pmid:17876900
|
Zhou J et al. |
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. |
2006 |
World J. Gastroenterol. |
pmid:16718799
|
Li DW et al. |
Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. |
2015 |
World J. Gastroenterol. |
pmid:26034369
|
Guo YW et al. |
Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients. |
2016 |
World J. Gastroenterol. |
pmid:27350740
|
Liu F et al. |
Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. |
2009 |
World J. Gastroenterol. |
pmid:19701975
|
Schumacher G et al. |
Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth. |
2005 |
World J. Gastroenterol. |
pmid:15770715
|
Takeichi T et al. |
Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver. |
2009 |
World J. Gastroenterol. |
pmid:19960569
|
Hilgard P et al. |
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. |
2006 |
World J. Gastroenterol. |
pmid:16521181
|
Eshraghian A et al. |
Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level. |
2017 |
World J. Gastroenterol. |
pmid:28275302
|
Jiang JW et al. |
Optimal immunosuppressor induces stable gut microbiota after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:30228781
|
Liu C et al. |
Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro. |
2005 |
World J. Gastroenterol. |
pmid:16437685
|
Del Bello A et al. |
High tacrolimus intra-patient variability is associated with graft rejection, and donor-specific antibodies occurrence after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:29713132
|
Meier J and Sturm A |
Current treatment of ulcerative colitis. |
2011 |
World J. Gastroenterol. |
pmid:21912469
|
Akamatsu N et al. |
Late-onset acute rejection after living donor liver transplantation. |
2006 |
World J. Gastroenterol. |
pmid:17075982
|
Larsen FS et al. |
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. |
2007 |
World J. Gastroenterol. |
pmid:17589903
|
Higashi H et al. |
First successful perinatal management of pregnancy after ABO-incompatible liver transplantation. |
2017 |
World J. Gastroenterol. |
pmid:28210092
|
Shao ZY et al. |
Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. |
2012 |
World J. Gastroenterol. |
pmid:22408361
|
Indriolo A and Ravelli P |
Clinical management of inflammatory bowel disease in the organ recipient. |
2014 |
World J. Gastroenterol. |
pmid:24707135
|
Shen T et al. |
Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. |
2015 |
World J. Gastroenterol. |
pmid:26034381
|